Volume 15, Number 9—September 2009
Chicken Consumption and Use of Acid-Suppressing Medications as Risk Factors for Campylobacter Enteritis, England
|Variable||PAF, %||SE||95% CI|
|Previous Campylobacter infection||2.6||1.37||0.0–5.3|
|Proton pump inhibitor use in previous 28 days||10.4||1.70||7.0–13.6|
|Acquisition of dog in previous month||1.2||1.10||0.0–3.3|
*PAF, population–attributable fraction; CI, confidence interval.
1The Campylobacter Case–Control Study Group comprises the following: Sarah J. O’Brien (Manchester University); Clarence C. Tam, Craig D. Higgins, Laura C. Rodrigues, and Brendan W. Wren (London School of Hygiene and Tropical Medicine); Keith R. Neal (University of Nottingham); Bob Owen and Judith Richardson (Health Protection Agency Centre for Infections); Bharat C. Patel (Health Protection Agency Collaborating Centre, North Middlesex Hospital); Peter Sheridan (North East and Central London HPU); John Curnow (Cheshire and Merseyside HPU); Ken Lamden (Cumbria and Lancashire HPU); and Sally Millership (Essex HPU).
- Page created: December 07, 2010
- Page last updated: December 07, 2010
- Page last reviewed: December 07, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)